Dimeric and hybrid anti-Alzheimer drug candidates.

  title={Dimeric and hybrid anti-Alzheimer drug candidates.},
  author={Diego Mu{\~n}oz-Torrero and Pelayo Camps},
  journal={Current medicinal chemistry},
  volume={13 4},
In the last decade much attention has been paid to the development of metabolically non-reversible dimeric or hybrid compounds, which combine two structural units of one or two lead compounds of interest for the treatment of Alzheimer's disease. As a consequence of their capability to simultaneously interact with two binding sites of the same biological… CONTINUE READING